Mubadala Investment Company has announced an investment in South Korea’s largest dental implant material manufacturer, Osstem Implant (Osstem), in partnership with MBK Partners and Unison Capital.
Focusing on the value segment in more than 30 international markets, Osstem is the world’s fourth largest dental implant material manufacturer. With manufacturing facilities in Korea and the United States, it provides implants as well as dental materials, digital equipment, and a full range of auxiliary services.
Osstem focuses on helping dentists provide their patients with total dental treatment solutions that are convenient for both doctors and patients. The company trains more than 110,000 dentists globally every year through its network of 120 dedicated training centers.
Camilla Macapili Languille, Head of Life Sciences at Mubadala Investment Company, said that with the growing prevalence of dental disorders and demand for cosmetic dentistry across the globe, access to comprehensive dental solutions plays a vital role in improving public health.
She said that they were pleased to partner with MBK Partners and Unison Capital to support Osstem in scaling its best-in-class dental solutions in the high-growth value segment to better serve doctors and patients across the globe.
Luca Molinari, Head of Asia, Direct Investments at Mubadala Investment Company, said that there were several attractive opportunities in the South Korean market and the company is impressed with the quality of the equity partners and the management team they were backing as part of this transaction. We look forward to supporting the next phase of Osstem’s growth.
Investments in Healthcare
Mubadala, the UAE’s Sovereign Wealth Fund, has assets of more than $250 billion, invests on behalf of Abu Dhabi’s government as part of the Emirates efforts to move away its dependence on hydrocarbon revenues. The sovereign fund is keen on investing in health care, life sciences, consumer-focused businesses, renewable energy, and the mobility sectors.
In 2021, Mubadala Investment Company and a group of other investors have bought a 46.9% stake in South Korean Botox maker Hugel.
The consortium led by CBC Group, Asia’s largest healthcare investment company, signed an agreement to acquire the stake in Hugel, which has a market capitalisation of more than $2.5 billion.
South Korea’s GS Holdings and private equity company IMM Investment, which has more than $4.7 billion of assets under management, are also part of the investor group that bought the stake from Bain Capital.
Osstem Implant is a leading implant company in Korea that makes some of the most popular implant products both in Korea and abroad. It has developed into a total dental solution company that offers not only the physical equipment required in dentistry, but also the IT services dental clinics need.
“Digital Dentistry” identifies risk factors of implant surgery in advance to help plan comprehensive and systematic surgery procedures, which is why it has become a major point of interest to everyone in the dental industry.
In order to provide comprehensive solutions designed to help build an industry environment suited to digital dentistry, Osstem Implant will continue its R&D and innovation with passion and relentless determination to take on new challenges in the pursuit of new technologies.